The shares of Plains GP Holdings, L.P. (NYSE:PAGP) has been pegged with a rating of Outperform by Wolfe Research in its latest research note that was published on June 13th, 2019. Wolfe Research wasn’t the only research firm that published a report of Plains GP Holdings, L.P., with other equities research analysts also giving their opinion on the stock. Goldman advised investors in its research note published on January 3rd, 2019, to Buy the PAGP stock. The stock had earned Buy rating from Jefferies when it published its report on December 20th, 2018. The stock was given Outperform rating by Credit Suisse in its report released on October 11th, 2018. BofA/Merrill was of a view that PAGP is Buy in its latest report on September 11th, 2018. Stifel thinks that PAGP is worth Hold rating. This was contained in the firm’s report on August 8th, 2018 in which the stock’s price target was also moved to $26.
Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 3 believe it has the potential for further growth, thus rating it as Hold while 8 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $27.71. The price of the stock the last time has raised by 16.07% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 29.37.
The shares of the company added by 1.00% during the trading session on Tuesday, reaching a low of $21.85 while ending the day at $22.25. During the trading session, a total of 2.27 million shares were traded which represents a -42.64% decline from the average session volume which is 1.59M shares. PAGP had ended its last session trading at 22.03. Plains GP Holdings, L.P. currently has a market cap of $6.42B, while its P/E ratio stands at 7.09, while its P/E earnings growth sits at 0.19, with a beta of 1.13. Plains GP Holdings, L.P. debt-to-equity ratio currently stands at 4.77, while its quick ratio hovers at 0.90. PAGP 52-week low price stands at $19.17 while its 52-week high price is $26.99.
The company in its last quarterly report recorded $0.40 earnings per share which is below the $0.41 predicted by most analysts. The Plains GP Holdings, L.P. generated $8,253.00 million in revenue during the last quarter, which is slightly higher than the $7,903.97 million predicted by analysts. In the second quarter last year, the firm recorded $0.92 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -130%. Plains GP Holdings, L.P. has the potential to record 3.14 EPS for the current fiscal year, according to equities analysts.
Investment analysts at KeyBanc Capital Markets published a research note on July 15th, 2019 where it informed investors and clients that WestRock Company (NYSE:WRK) is now rated as Underweight. Their price target on the stock stands at $32. Goldman also rated WRK as Upgrade on January 3rd, 2019, with its price target of $116 suggesting that WRK could surge by 24.79% from its current share price. Even though the stock has been trading at $33.22/share, analysts expect it to surge higher by 4.30% to reach $46.07/share. It started the day trading at $35.02 and traded between $32.89 and $34.65 throughout the trading session.
A look at its technical shows that WRK’s 50-day SMA is 36.16 while its 200-day SMA stands at 38.93. The stock has a high of $57.23 for the year while the low is $32.01. The company’s P/E ratio currently sits at 12.23, while the P/B ratio is 0.75. At the moment, only of WestRock Company shares were sold short. The company’s average trading volume currently stands at 2.08M shares, which means that the short-interest ratio is just 2.21 days. Over the past seven days, the company moved, with its shift of -0.49%. Looking further, the stock has dropped -6.83% over the past 90 days while it lost -10.49% over the last six months.
The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. The Vanguard Group Inc bought more WRK shares, increasing its portfolio by +0.62% during the last quarter. This move now sees The Vanguard Group Inc purchasing 174,210 shares in the last quarter, thus it now holds 28,332,116 shares of WRK, with a total valuation of $1,021,372,782. Capital Research Management Co meanwhile sold more WRK shares in the recently filed quarter, changing its stake to $772,896,643 worth of shares. BlackRock Fund Advisors followed the path by increasing its WRK portfolio by +29.13% in the quarter. This means that BlackRock Fund Advisors bought 4,714,910 shares in the last quarter and now controls 20,900,092 shares of the WRK stock, with the valuation hitting $753,448,317.
Similarly, JPMorgan Investment Management I decreased its WestRock Company shares by -7.61% during the recently filed quarter. After selling -636,053 shares in the last quarter, the firm now controls 7,720,071 shares of WestRock Company which are valued at $278,308,560. In the same vein, LSV Asset Management increased its WestRock Company shares by during the most recent reported quarter. The firm bought 132,522 shares during the quarter which increased its stakes to 6,205,125 shares and is now valued at $223,694,756. Following these latest developments, around 0.80% of WestRock Company stocks are owned by institutional investors and hedge funds.